- Home
- SVM vs PRAX Comparison
SVM vs PRAX Comparison
Compare SVM & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- PRAX
- Stock Information
- Founded
- SVM N/A
- PRAX 2015
- Country
- SVM Canada
- PRAX United States
- Employees
- SVM N/A
- PRAX N/A
- Industry
- SVM Precious Metals
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- SVM Basic Materials
- PRAX Health Care
- Exchange
- SVM Nasdaq
- PRAX Nasdaq
- Market Cap
- SVM 1.0B
- PRAX 1.2B
- IPO Year
- SVM N/A
- PRAX 2020
- Fundamental
- Price
- SVM $4.09
- PRAX $71.51
- Analyst Decision
- SVM Strong Buy
- PRAX Strong Buy
- Analyst Count
- SVM 1
- PRAX 9
- Target Price
- SVM $5.10
- PRAX $146.33
- AVG Volume (30 Days)
- SVM 3.4M
- PRAX 317.5K
- Earning Date
- SVM 11-07-2024
- PRAX 11-06-2024
- Dividend Yield
- SVM 0.63%
- PRAX N/A
- EPS Growth
- SVM 63.39
- PRAX N/A
- EPS
- SVM 0.29
- PRAX N/A
- Revenue
- SVM $241,357,000.00
- PRAX $1,605,000.00
- Revenue This Year
- SVM $31.59
- PRAX N/A
- Revenue Next Year
- SVM $13.22
- PRAX N/A
- P/E Ratio
- SVM $13.79
- PRAX N/A
- Revenue Growth
- SVM 16.71
- PRAX N/A
- 52 Week Low
- SVM $2.22
- PRAX $14.78
- 52 Week High
- SVM $5.32
- PRAX $86.93
- Technical
- Relative Strength Index (RSI)
- SVM 41.75
- PRAX 48.39
- Support Level
- SVM $3.83
- PRAX $58.84
- Resistance Level
- SVM $4.03
- PRAX $86.93
- Average True Range (ATR)
- SVM 0.22
- PRAX 6.24
- MACD
- SVM -0.08
- PRAX -0.59
- Stochastic Oscillator
- SVM 24.37
- PRAX 45.11
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.